Brief: A1m Pharma Q4 Pre-tax Loss Narrows To SEK 15.0 Million
Feb 23 (Reuters) - A1m Pharma Ab A1M.ST :
* Q4 PRETAX LOSS SEK 15.0 MILLION VERSUS LOSS SEK 21.7
MILLION
YEAR AGO
* PROPOSES NO DIVIDEND FOR 2017
Source text for Eikon: ID:nBQN1kdQG3
Further company coverage: A1M.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover